RARECELLS
Rarecells, Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests. These tests are based on the ISET® platform technology that is able to extract from blood cancer cells from any type of cancer. Cancer cells extracted by ISET® are then diagnostically identified through immune-morpho molecular analyses combined with image analyses and AI. This approach is believed to be a significant advancement in the highly sensitive non-invasive detection of cancer’s signals providing a powerful tool for early cancer detection through the identification of the first circulating cancer cells.
RARECELLS
Industry:
Biotechnology Health Care
Founded:
2010-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.rarecells.com
Total Employee:
11+
Status:
Active
Total Funding:
13 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Apache
Similar Organizations
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.rarecells.com Semrush global rank: 2.85 M Semrush visits lastest month: 5.67 K
- Host name: webredir.vip.gandi.net
- IP address: 217.70.184.38
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Rarecells"
Home - Rarecells
At Rarecells, we are physicians and scientists using clinical experience and scientific first-in-class innovation to develop life-saving tests and bring them to patients. By leveraging state-of-the …See details»
About Us - Rarecells
We know that accurate, early cancer detection has the potential to save millions of lives. Every day our talented and dedicated team works with experts to make the technology that can …See details»
Rarecells - Crunchbase Company Profile & Funding
Rarecells, Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests. These tests are based on the ISET® platform …See details»
Rarecells - VentureRadar
Website: https://www.rarecells.com/ Our mission is to disrupt today's cancer patient care toward personalized medicine and earlier detection of the disease for the benefit of people’s life, …See details»
Rarecells Company Profile 2024: Valuation, Funding & Investors
Developer of a biotechnology platform designed to facilitate early-stage detection of cancer using circulating tumor cells.See details»
CONTACT US - Rarecells
Rarecells, Inc. Alexandria LaunchLabs-Columbia. 3960 Broadway, 6th Floor. New York, NY 10032. FRANCE Rarecells Diagnostics SAS 101 rue de Sèvres 75 280 Paris Cedex 06 …See details»
Rarecells - Advisory Team - The Org
The Advisory Team at Rarecells provides strategic guidance and expertise to enhance the development and commercialization of innovative Early Cancer Detection tests.See details»
Rarecells, Inc. to fund a clinical study at Columbia ... - Newswire
Nov 9, 2021 · Rarecells, Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests. These tests are based on the …See details»
Jean-Yves Blay - Advisor at Rarecells - The Org
Dr. Jean-Yves Blay is Professor of Medicine at the Université Claude Bernard in Lyon, France, and the Scientific Director of the Canceropole Lyon Rhône Alpes, a network of more than 1500 researchers and physicians working in the field of …See details»
Alessandra Decina - Chief Operating Officer at Rarecells - The Org
Alessandra joined Rarecells Diagnostics in 2015 as the Quality Assurance and Regulatory Affairs Manager, supporting the development of new products, and the expansion of operations. …See details»
Rarecells, Inc. announces successful Series A funding, reaching $13 ...
NEW YORK and PARIS, Dec. 9, 2021 /PRNewswire/ -- Rarecells, Inc., an innovative Liquid Biopsy company developing non-invasive tests for early cancer diagnosis, announced today …See details»
ISET® Team - ISET® - Isolation by Size of Tumor cells
Behind the ISET® technology is a team of dynamic people working to provide the best diagnostic method for cancer patients, helping to save lives through early diagnosis of invasive cancers, …See details»
Rarecells - Products, Competitors, Financials, Employees, …
Rarecells Inc. is a biotechnology company focused on the development of non-invasive early cancer detection tests based on Rarecells' ISET® platform technology able to extract from …See details»
Press release : Rarecells, Inc. announces successful Series A …
NEW YORK and PARIS, Dec. 9, 2021 — Rarecells, Inc., an innovative Liquid Biopsy company developing non-invasive tests for early cancer diagnosis, announced today the closing of a $5 …See details»
ISETbyRarecells - Isolation by Size of Tumor cells
With Rarecells ISET® technology is a proven method to detect difficult to diagnose tumors before they spread, allowing for less traumatic therapy and a long and fruitful life after cancer.See details»
Rarecells, Inc. announces a breakthrough publication on …
Jul 20, 2023 · Rarecells Inc. is a biotechnology company focused on the development of non-invasive early cancer detection tests based on Rarecells' ISET® platform technology able to …See details»
Screening for Circulating Tumour Cells Allows Early Detection
Aug 27, 2017 · Several technologies have been developed to identify CTC, including the validated Isolation-by-Size-of-Epithelial-Tumour (ISET, Rarecells) technology, combining blood filtration …See details»
Rarecells, Inc. announces successful Series A funding ... - Newswire
NEW YORK and PARIS, Dec. 9, 2021 /CNW/ -- Rarecells, Inc., an innovative Liquid Biopsy company developing non-invasive tests for early cancer diagnosis, announced today the …See details»
Governor DeWine and Governor Whitmer Place Wager on The Game
1 day ago · In honor of the life and service of State Senator Schuring, Governor DeWine has ordered the flags of the United States and the state of Ohio to be lowered upon all public …See details»
Rarecells - Find the latest news from Rarecells Diagnostics
To find out about what Rarecells is doing around the globe explore our featured news or contact our team at [email protected]. Press release : Rarecells, Inc. announces successful …See details»